Propylthiouracil
8 NDCs across 7 manufacturers|8 Generic,0 Brand
Propylthiouracil is used to treat goiter and thyroid crisis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Propylthiouracil across 38,000 claims for 8,860 beneficiaries.
Propylthiouracil is available as 8 NDCs from 7 manufacturers (8 generic, 0 brand), with NADAC prices from $0.27 to $0.27 per EA — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
7
competing in market
Price Spread
$0.27 – $0.27
per EA
7d Activity
avg -0.5% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Endo USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Thyroid Hormone Synthesis Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing PROPYLTHIOURACIL(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PROPYLTHIOURACIL 50 MG TABLET | $0.2724 per EA | — |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
PROPYLTHIOURACIL 50 MG TABLET | $0.2687 per EA | -0.50% |
Frequently Asked Questions
What is Propylthiouracil used to treat?
Propylthiouracil is used to treat goiter and thyroid crisis, per the National Library of Medicine's MED-RT classification.
When did Propylthiouracil become available as a generic?
FDA approved the first generic Propylthiouracil (ANDA) on Jan 1, 1982. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Propylthiouracil?
In 2024, Medicare Part D spent $2 million on Propylthiouracil across 38,000 claims for 8,860 beneficiaries.
How many Propylthiouracil products are on the market?
The Propylthiouracil drug market contains 8 NDCs from 7 manufacturers — 8 generic and 0 brand products.
What is the price range for Propylthiouracil?
NADAC reference prices for Propylthiouracil range from $0.2687 to $0.2724 per EA — a 1% difference between cheapest and most expensive.
Which manufacturers make Propylthiouracil?
7 manufacturers list Propylthiouracil in NADAC. Ranked by number of NDCs, the largest are Endo USA Inc. (2), Actavis Pharma, Inc. (1), Macleods Pharmaceuticals Limited (1), Chartwell RX LLC (1), Teva Pharmaceuticals USA Inc. (1).
How has the price of Propylthiouracil changed recently?
Over the past 7 days, 0 Propylthiouracil NDCs rose and 7 fell, with a market-wide average change of -0.5%.